title: Hepatic resection for colorectal metastases.
abstract: The liver represents a common site for metastasis in colorectal cancer. Improvements in patient selection and surgical techniques has resulted in improved outcomes following hepatic metastasectomy with large series reporting 5- and 10-year overall survival rates of 40% and 20%, respectively. In recent years, criteria for resectability has expanded with the use of forced liver hypertrophy and staged resection. The role of perioperative chemotherapy remains controversial with a slight increase in survival and operative morbidity.
authors: Section of Hepatopancreatobiliary Surgery, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York.
authors: Timothy L
authors: TL
authors: Frankel
authors: Michael I
authors: MI
authors: D'Angelica
mesh_terms: D002496:Central Venous Pressure; D017024:Chemotherapy, Adjuvant; D015179:Colorectal Neoplasms / Q000473:pathology*; D006801:Humans; D007261:Infusions, Intra-Arterial; D008113:Liver Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000556:secondary* / Q000601:surgery*; D059146:Metastasectomy / Q000379:methods*; D014057:Tomography, X-Ray Computed
keywords: colon cancer; hepatectomy; metastases